Psychiatry Curbside Top 10
|
|
- Alannah Richards
- 6 years ago
- Views:
Transcription
1 Psychiatry Curbside Top 10 April 27, 2018 Laurel Ralston, DO Staff Psychiatrist Director of Psych-Oncology, Taussig Cancer Institute
2 Objectives Review current diagnostic and prescribing guidelines for depression and anxiety disorders Discuss non-pharmacologic treatment alternatives Recognize patients at risk for psychiatric crisis
3 #1.Why are primary care doctors responsible for providing most mental health services in the US?
4 In 2017, 60% of psychiatrists were 55 or older
5 Boston Med Surg J 1923; 189: DOI: /NEJM The importance of psychiatry to the medical profession may be measured with a fair degree of accuracy by the prominence of the part played by mental diseases as a factor in public health problems.
6 Depression & Anxiety Screening Assess further if: PHQ-2= 3 or higher or GAD-2= 3 or higher
7
8 #2. Is DSM-5 relevant for the primary care provider? DSM Diagnoses ( ) DSM-I DSM-II DSM-III DSM-IV DSM-5
9 DSM-5 Depression Specifiers Depression specifiers: - Mixed features - Atypical features - Psychotic features - Anxious distress - Melancholic features - Peripartum onset - Seasonal onset Add mood stabilizer? Bupropion? Activating SSRI/SNRI? Add antipsychotic?
10 DSM v NIMH Symptom-based diagnosis, once common in other areas of medicine, has been largely replaced in the past half century symptoms alone rarely indicate the best choice of treatment. Patients with mental disorders deserve better. NIMH has launched the Research Domain Criteria (RDoC) project to transform diagnosis by incorporating genetics, imaging, cognitive science, and other levels of information to lay the foundation for a new classification system. -Thomas Insel, NIMH Director
11 Psychiatry On the Horizon Imaging Biomarkers -CRP, IL-6, TNF-α Glutamate - ketamine Glial Cells PET Scan: depressed brain (top), treated depression (bottom) PET Scan: normal (left), manic phase (right) -Ashwell, Ken W. S. & Restak, Richard M. (2012). The brain book : development, function, disorder, health. South Yarra, Vic : Palgrave Macmillan -Carter, R., Aldridge, S., Page, M. (., Parker, S., Frith, C. D., Frith, U., & Shulman, M. B. (2009). The human brain book.1st American ed. London [England]: New York, N.Y.
12 #3. When Should I Prescribe a Medication? Image:
13 Prescribing considerations Past medication trials (personal, family) Psychiatric co-morbidities Medical co-morbidities Age Drug interactions (eg tamoxifen) Cost Pregnant/Breastfeeding -
14 #4. Which antidepressants work best?
15 SSRIs Medication Approved Indication Usual Dosage Max (mg/day) Zoloft (sertraline) MDD Social anxiety disorder mg/day mg/day Panic disorder mg/day 200 OCD mg/day 200 PTSD mg/day 200 PMDD mg/day 150 Paroxetine (Paxil) MDD GAD 20-50mg/day ( ) 20-50mg/day 50 (62.5) 50 Social Anxiety Disorder 20-60mg/day ( ) 60 (37.5) Panic disorder 20-40mg/day ( ) 60 (75) PTSD 20-60mg/day 60 PMDD ( mg/day) (25)
16
17 SSRIs Medication Approved Indication Usual Dosage Maximum (mg/day) Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) MDD 20-40mg/day 40 MDD GAD MDD OCD 10-20mg/day 10-20mg/day 20-80mg/day qam or BID 20-60mg/day, qam or BID Panic disorder 20-60mg/day 60 Bulimia 20-60mg/day 60 PMDD 20-60mg/day 60 Fluvoxamine (Luvox) OCD mg/day, divided BID 300
18 SNRIs Medication Approved Indication Usual Dosage Maximum Duloxetine (Cymbalta) Venlafaxine (Effexor) Desvenlafaxine (Pristiq) Milnacipran (Savella) Levomilnacipran (Fetzima) MDD GAD Fibromyalgia MDD GAD Social Anxiety Panic Disorder 40-60mg/daily 60mg/day 60 mg/day mg/day mg/day 75mg/day mg/day 120mg 120mg 60mg 225mg 225mg 75mg 225mg MDD 50mg/day 50mg Fibromyalgia 100mg/day 200mg MDD mg/day 120mg
19 Medication Approved Indications Usual Dosage Maximum Vilazodone (Viibryd) Vortioxetine (Trintellix) Trazodone Multimodal 5HT Antagonists MDD 20-40mg/day 40mg MDD 20mg/day 20mg MDD Insomnia* (off label) mg/day (divided BID or TID) mg qhs 400mg 200mg Noradrenergic-specific serotonin antidepressant Medication Approved Indications Usual Dosage Maximum Mirtazapine (Remeron) MDD 15-45mg/qhs 45mg
20 NDRI Medication Approved Indications Usual Dosage Maximum Bupropion (Wellbutrin) MDD 300mg (divided TID) (IR) 300mg (divided BID) (SR) 450mg 400mg BupropionXL MDD, SAD 300mg/day 450mg Aplenzin MDD, SAD 348mg/day 522mg
21 #5. What do I tell my patient about risks & side effects?
22 Suicidal thoughts and behaviors FDA black box warning (2004) - Adolescents and young adults Based on 24 studies; 4400 patients - Prevalence of suicidal thinking and behavior in first few months of starting antidepressant? 4% in antidepressant group; 2% in placebo group No actual suicides
23
24 Addressing Sexual Side Effects Patients are unlikely to initiate conversation dose or switch to bupropion, mirtazapine Augment with bupropion, sildenafil Anita H. Clayton, Harry A. Croft & Lata Handiwala (2014) Antidepressants and Sexual Dysfunction: Mechanisms and Clinical Implications, Postgraduate Medicine, 126:2,
25 Serotonin syndrome
26 #6. What augmentation or alternative treatments are available? Medications Bright light therapy Nutrition/Exercise Brain Stimulation Pharmacokinetic gene testing
27 Drug Augmentation in Treatment Resistant Depression Huynh NN, McIntyre RS. What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis. Primary Care Companion to The Journal of Clinical Psychiatry. 2008;10(2):91-96.
28 Bright light therapy Proven efficacy in depression with seasonal onset Relatively inexpensive ($ ), sometimes lighbox is covered by insurance Negligible side effects, but can potentially evoke manic symptoms in bipolar patients
29 Nutrition Vitamin B6 - Needed to produce serotonin Omega 3 FA (DHA) - Promotes production of brain derived neurotrophic factor (BDNF); protect neurons, birth of new brain cells Jacka et al. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Medicine (2017) 15:23
30 Nutrition Role of Inflammation - Prebiotics Food for good gut bacteria - Probiotics Live bacteria and yeast; replenish good gut bacteria Vitetta, L., Bambling, M., & Alford, H. (2014). The gastrointestinal tract microbiome, probiotics, and mood.inflammopharmacology, 22(6),
31 Electroconvulsive therapy Treatment option with highest remission rates (80%) Frequently M/W/F x3 weeks, then maintenance monthly as needed Risk of memory impairment No absolute contraindications National Institutes of Health: National Institute of Mental Health. Brain Stimulation Therapies. Accessed April 26, 2018.
32 Transcranial Magnetic Stimulation 50% remission rates Pros: non-invasive, negligible side effects Cons: time intensive, unreliable insurance coverage, limited number of clinicians offering TMS Cress K, Brown K, Landry B, Zotyka R. Treatment of unipolar, non-psychotic major depressive disorder with transcranial magnetic stimulation: a retrospective evaluation examining acute and long-term efficacy of TMS during routine clinical practice. Poster presentation at: 2016 Annual Meeting of the American Psychiatric Association; May 14-18, 2016; Atlanta, GA.
33 Psychopharmacologic gene testing Identify CYP450 variant metabolizers - Most psych medications metabolized via 3A4, 2D6, 1A2 Presence of specific genes associated with medication adverse effects - Serotonin transporter gene promoter polymorphism (5-HTTLPR)
34 #7. Is it okay to prescribe benzos? Lack of data on best practice guidelines Increased risk for adverse effects in patients that are elderly, have pulmonary disease or history of substance abuse Set clear expectations with patient at onset re: anticipated duration of treatment Relationship between benzos and dementia is unclear
35 Benzo Equivalency Chart Approx Oral Equivalency (mg) Time to peak level, hours Alprazolam (Xanax) Lorazepam (Ativan) Diazepam (Valium) Clonazepam (Klonopin) Tempazepam (Restoril) Half-life, hours
36 #8. Is there evidence-based psychotherapy? Cognitive behavioral therapy Dialectical behavioral therapy Behavioral activation Motivational interviewing Mobile apps Depression/Anxiety Borderline PD Depression Depression/Substance Limited Evidence
37 Not Just Talk Effective psychotherapy can elicit a biological response - Changes on neuroimaging - Changes in cortisol, oxytocin - Biofeedback parameters
38 Mirror Neurons Common activation of emotionally significant parts of the cortex, whether the emotion is personal or a third-person observation, may be the anatomical basis for empathy In this PET scan, the same sets of nerve cells in the cerebral cortex are activated when watching an action as when performing it, evidence of mirror neurons at work
39 #9. How can I identify patients at suicide risk?
40
41
42 Patients with suicidal thoughts MYTH: Asking about suicide makes patients suicidal (it does not!) Screening tool: Columbia Suicide Scale Know the guidelines for involuntary hospitalization in your state Have a written office protocol for how to handle an actively suicidal patient
43 Patient Resources National Suicide Prevention Lifeline, TALK (8255) or Live Online Chat SAMHSA Treatment Referral Helpline, SAMHSA7 National Alliance for Mental Illness (NAMI)
44 #10. How Can We Improve PCP and MH Provider Collaboration? Telemedicine Project ECHO (Extension of Community Health Outcomes) Collaborative Care Models
45
Psychiatry curbside: Answers to a primary care doctor s top mental health questions
Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other BUPROPION HCL WELLBUTRIN, 01653 WELLBUTRIN SR, WELLBUTRIN XL BUPROPION HBR APLENZIN 17050 16996 26198 CITALOPRAM CELEXA 10321 GPID 16344 HYDROBROMIDE DESVENLAFAXINE
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationQuick Guide to Common Antidepressants-Adults
Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationPHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES
PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14
More informationCOMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*
COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationPresentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationClinical Update on Management of Depression and Anxiety in the Primary Care Setting. Objectives: Why Is This Important?
Clinical Update on Management of Depression and Anxiety in the Primary Care Setting Kirstyn Kameg, DNP, PMHNP, BC University Professor PMHNP Program Coordinator Robert Morris University November 4, 2017
More information9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded
Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please
More informationTreatment of Major Depressive Disorder
Treatment of Major Depressive Disorder Sarah Mullowney, MD PGY3 Psychiatry Resident, University of Utah Paula Gibbs, MD Medical Director of 5 West at UUMC Clerkship Director MS III Psychiatric Rotation
More informationMajor Depression and Anxiety in Adolescents and Adults
Major Depression and Anxiety in Adolescents and Adults Miggie Greenberg, M.D. Associate Professor of Psychiatry St. Louis University School of Medicine greenbml@slu.edu *NO DISCLOSURES* OBJECTIVES * Recognize
More informationFamily Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University
APPROACH TO DEPRESSION IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal., Quebec. Jon Davine, CCFP, FRCP(C) Associate Professor, McMaster University DISCLOSURE Speaker/Presenter Disclosure
More informationNew Patient Questionnaire
4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with
More informationSteps for Initiating Electroconvulsive Therapy Treatment
Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More information8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation
Managing Psychiatric Conditions in Primary Care Beyond the Basics Source: US National Library of Medicine, Images from the History of Medicine Luis Berrios, DNP, MHA, ANP, PMHNP Internal Medicine & Primary
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationERIC J. NESTLER, MD, PhD
ERIC J. NESTLER, MD, PhD NASH FAMILY PROFESSOR OF NEUROSCIENCE CHAIR, DEPARTMENT OF NEUROSCIENCE DIRECTOR, FRIEDMAN BRAIN INSTITUTE MOUNT SINAI SCHOOL OF MEDICINE Please do not use or distribute without
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationRealities of Depression in Primary Care Setting
Realities of Depression in Primary Care Setting Jaroslava Salman, MD Department of Supportive Care Medicine Division of Psychiatry Click to edit Master Presentation Date August 4 th 2018 Disclosure I have
More informationDaniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School
Daniel Suzuki, MD Adjunct Clinical Associate Professor of Psychiatry, USC Keck School of Medicine Clinical Adjunct Professor/Faculty, Graduate School of Psychology, Fuller Theological Seminary Medical
More informationAdult Depression - Clinical Practice Guideline
1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)
More informationBRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.
BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationIt is the policy of health plans affiliated with Centene Corporation that Seroquel XR is medically necessary when the following criteria are met:
Clinical Policy: (Seroquel XR) Reference Number: CP.PMN.64 Effective Date: 12.01.14 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationTreatment of Depression in the Primary Care Office
Treatment of Depression in the Primary Care Office Paul E.A. Glaser, MD, PhD Departments of Psychiatry, Pediatrics and Anatomy & Neurobiology University of Kentucky November 5, 2010 Disclosures of Potential
More informationAntidepressant Medication Therapy in Primary Care July 25, 2013
New York State Collaborative Care Initiative Antidepressant Medication Therapy in Primary Care July 25, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationFocusing on Depression in the Community. Kelly N. Gable, Pharm.D., BCPP Associate Professor SIUE School of Pharmacy
Focusing on Depression in the Community Kelly N. Gable, Pharm.D., BCPP Associate Professor SIUE School of Pharmacy Disclosure and Conflict of Interest Dr. Gable declares no conflicts of interest, real
More informationIlluminating the Black Box: Antidepressants, Youth and Suicide
Illuminating the Black Box: Antidepressants, Youth and Suicide David H. Rubin, M.D. Executive Director, MGH Psychiatry Academy Director, Postgraduate Medical Education Director, Child and Adolescent Psychiatry
More informationAverage dose zoloft for ocd and anxiety
Average dose zoloft for ocd and anxiety Gogamz Menu DESCRIPTION. Selective serotonin reuptake inhibitor (SSRI). Approved for depression, OCD, panic disorder, PTSD, premenstrual-dysphoric disorder (PMDD),
More informationObjectives: Lifetime prevalence. Neurotransmitters of interest
Kelly Kll M. Rock, DNP, CRNP 11/5/11 Objectives: Identify lifetime prevalence of depressive and anxious disorders. Recognize the social and economic burden of depressive and anxious disorders. Understand
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2012 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationResistance is not futile: working with refractory depression and anxiety
Resistance is not futile: working with refractory depression and anxiety Divulgation des conflits d intérêts Conseil consultatif ou comité analogue Essais cliniques ou études Honoraires ou autres revenus
More informationMAJOR DEPRESSION CLINICAL PRACTICE GUIDELINE
MAJOR DEPRESSION CLINICAL PRACTICE GUIDELINE Reviewed and Updated by the Behvioral Health Subcommittee 7/20/2017 Topic Purpose Access Assessment 7/2017 Recommendations SummaCare Health Plan bases its Clinical
More informationClinical Policy: Levomilnacipran (Fetzima) Reference Number: HIM.PA.125 Effective Date: Last Review Date: 11.18
Clinical Policy: (Fetzima) Reference Number: HIM.PA.125 Effective Date: 12.01.17 Last Review Date: 11.18 Line of Business: HIM Revision Log See Important Reminder at the end of this policy for important
More informationJudges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
More informationPRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA
CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationFROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY
13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationDepression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms
Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)
More informationMixing and Matching: Layering Medications as Family Physicians
Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples
More informationDiabetes and Depression. Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C
Diabetes and Depression Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C 2008 Learning Objectives State the risk factors for depression Identify the vulnerability
More informationOptimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE
Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Chan-Hyung Kim, MD Severance Mental Health Hospital Institute of Behavioral Science in Medicine Diagnostic Criteria Pyramid Etiologic Pathophysiologic
More informationObjectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS
MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private
More informationBefore you try another medication, try asking your DNA
Before you try another medication, try asking your DNA It s not you, it s your genetics If you re having trouble finding a medication that works for you, don t give up hope. Here s the thing we all respond
More informationPharmacy Technician Objectives. Pharmacist Objectives. Pre-Test Question 2. Pre-Test Question 1 9/27/2016. Disclosure and Conflict of Interest
Disclosure and Conflict of Interest Focusing on Depression in the Community Kelly N. Gable, Pharm.D., BCPP Associate Professor SIUE School of Pharmacy Dr. Gable declares no conflicts of interest, real
More informationClinical Policy: Vilazodone (Viibryd) Reference Number: CP.PMN.145 Effective Date: Last Review Date: Line of Business: HIM, Medicaid
Clinical Policy: (Viibryd) Reference Number: CP.PMN.145 Effective Date: 08.01.12 Last Review Date: 08.18 Line of Business: HIM, Medicaid Revision Log See Important Reminder at the end of this policy for
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Trintellix) Reference Number: CP.PMN.65 Effective Date: 05.01.15 Last Review Date: 08.18 Line of Business: HIM, Medicaid Revision Log See Important Reminder at the end of this policy
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationPsychiatric Consultant Role in Collaborative Care Sept 12, 2013
New York State Collaborative Care Initiative Psychiatric Consultant Role in Collaborative Care Sept 12, 2013 http://uwaims.org Presenter Building on 25 years of Research and Practice in Integrated Mental
More informationDuragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist
Pre - PA Allowance Quantity 30 patches every 90 days Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist Age 2 years of age or older Diagnosis Patient must have
More informationCommon Psychiatric Disorders at the End of Life
Common Psychiatric Disorders at the End of Life Allison E Jordan MD, HMDC Medical Director of Palliative Medicine Christian Hospital NE and Alton Memorial Hospital Associate Medical Director, BJC Hospice
More informationMy Background. Presentation Outline. Common Psychiatric Disorders at the End of Life 9/13/2018
Common Psychiatric Disorders at the End of Life Allison E Jordan MD, HMDC Medical Director of Palliative Medicine Christian Hospital NE and Alton Memorial Hospital Associate Medical Director, BJC Hospice
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Update: 2013 I have nothing to disclose Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California,
More informationPrescribing Medications for Anxiety and Depression (without getting anxious and depressed)
Prescribing Medications for Anxiety and Depression (without getting anxious and depressed) Stephen Warnick Jr., M.D. Assistant Professor Departments of Family Medicine and Psychiatry Disclosures None 2
More informationWhere to from Here? Evidence-Based Strategies for Treatment of Refractory Depression
Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability
More informationKari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington. Approach for doing differential diagnosis of PTSD
IN PRIMARY CARE June 17, 2010 Kari A. Stephens, PhD & Wayne Bentham, MD Psychiatry & Behavioral Sciences University of Washington Defining and assessing Approach for doing differential diagnosis of Best
More informationMORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)
Pre - PA Allowance Tablets & Suppositories Morphine sulfate tablets Morphine sulfate suppositories Oxymorphone tablets Hydromorphone tablets Hydromorphone suppositories 360 tablets per 90 days OR 360 suppositories
More informationPre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None
Pre - PA Allowance None Prior-Approval Requirements Prior authorization is not required if prescribed by an oncologist and/or the member has paid pharmacy claims for an oncology medication(s) in the past
More informationThe Latest in Treating Depression and Anxiety in Primary Care
The Latest in Treating Depression and Anxiety in Primary Care Wendy L. Wright MS, ANP-BC, FNP-BC, FAANP, FAAN, FNAP Adult/Family Nurse Practitioner Owner Wright & Associates Family Healthcare @ Amherst
More informationCommon Antidepressant Medications for Adults
(and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Antidepressant Agents Page 1 of 14 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Antidepressant Agents Prime Therapeutics will review Prior Authorization requests.
More informationAnxiety Disorders.
Anxiety Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationRecognizing Depression and Restoring Mood and Well- Being in the Older Patient
Recognizing Depression and Restoring Mood and Well- Being in the Older Patient Andreea L. Seritan, MD UC Davis Mini Medical School February 22, 2014 Objectives Review late life depression symptoms Review
More informationHappy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?
Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms
More informationDepression: Identification, Evaluation and Management in Primary Care
Depression: Identification, Evaluation and Management in Primary Care Primary Care Medicine: Update 2010 Rena K. Fox, M.D. Associate Professor of Clinical Medicine University of California, San Francisco
More informationHYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.
Pre - PA Allowance None Prior authorization is not required if prescribed by an oncologist. Prior-Approval Requirements Age 18 years of age or older Diagnosis Patient must have the following: 1. Pain,
More informationObjectives. Diagnostic Criteria DSM 5. Before we begin I should tell you that. General Diagnostics for Anxiety Disorders 08/02/2014
Before we begin I should tell you that ANTIDEPRESSANT USE IN ANXIETY, DEPRESSION AND BIPOLAR: HELPFUL OR HARMFUL? Rania Kattura, PharmD, MS, BCPP Clinical Assistant Professor University of Texas at Austin
More informationRichard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA
*We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening
More informationPsychiatric Medications. Positive and negative effects in the classroom
Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationManagement of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*
Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationPsychopharmacological Management of Depressive and Anxiety Disorders
Psychopharmacological Management of Depressive and Anxiety Disorders Waseem Ahmed, M.D Medical Director: Population Health and Dallas County Correctional System Email: waseem.ahmed@phhs.org Tel: 214-653-2927
More informationPrepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.
Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association
More informationPSYCHIATRY INTAKE FORM
Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.
More informationJoel V. Oberstar, M.D. 1
Diagnosis and Treatment of Depressive Disorders in Children and Adolescents Joel V. Oberstar, M.D. CEO & Chief Medical Officer Adjunct Assistant Professor of Psychiatry University of Minnesota Medical
More informationPharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests
Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) University of Texas Health Science Center San Antonio Pharmacotherapy Education and Research Center (PERC) 7703 Floyd Curl Drive - MSC 6220 San
More informationDepression. By Uju Chukwuka, BSN, RN.
Depression By Uju Chukwuka, BSN, RN. 1 2 What is Depression? Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. It affects how you feel, think and behave and
More informationAntidepressant Agents Step Therapy and Quantity Limit Program Summary
Antidepressant Agents Step Therapy and Quantity Limit Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-20,26,27,30,32-35,37-39,40,41,43 Drug MDD OCD PD GAD SAD PDD PTSD Bulimia Other Diagnos es Dosing
More informationPractice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association
Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association Our clinical advisor adds updated advice on electroconvulsive therapy, transcranial magnetic
More informationClinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant
The Clinical Significance of Anxiety Disorders and the DSM-5 Anxious Distress Specifier in Depressed Patients Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant Rhode Island
More informationPresenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy
Depression, Anxiety, PTSD: A Focus on Pharmacotherapy Robert L Page II, Pharm.D., MSPH, FHFSA, FCCP, FAHA Professor of Clinical Pharmacy Clinical Specialist, Division of Cardiology University of Colorado
More informationSUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816
SUTTER PHYSICIANS ALLIANCE (SPA) 2800 L Street, 7 th Floor Sacramento, CA 95816 SPA PCP Treatment & Referral Guideline Managing Depression in Older Adults Developed March 1, 2003 Revised September 21,
More informationGENERALIZED ANXIETY DISORDER (GAD) PRACTICE PRINCIPLE FOR PRIMARY CARE: ADULTS 18 AND OLDER
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationThe Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD and Kellie Bunn, PA-C What are functional GI
More informationDepression: Assessment and Treatment For Older Adults
Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca
More informationNon-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450
James A. Bourgeois, O.D., M.D. Vice Chair Clinical Affairs and Director, CL Service University of California San Francisco Non-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450 Localize! Sequence! 1
More informationDepressive Disorders A clinical overview. Dr. Scott Yarosh, Medical Director, Behavioral Health
Depressive Disorders A clinical overview Dr. Scott Yarosh, Medical Director, Behavioral Health Depressive Disorders What is depression? Complex series of conditions Physical component Emotional component
More information